These results show a striking similarity to the observations made in CML and AML cells, in which an increased activity and expression of GCNT1 led to an increase in Core 2 O-glycans, as compared to normal granulocytes 67. This evidence concerns the gene GCNT1 and chronic myelogenous leukemia, BCR-ABL1 positive.